Specialist Dr. Birkan Alayci

Specialist Dr. Birkan Alayci
Academic Title :
Specialist Dr.

Specialist Dr. Birkan Alayci is an Internal Medicine specialist practicing at Liv Hospital Vadistanbul. He has extensive expertise in managing metabolic health, diabetes, thyroid disorders, and preventive health through evidence-based clinical practices.

Education and Academic Qualifications

  • Doctor of Medicine, Dokuz Eylül University Faculty of Medicine, 2018
  • Specialization in Internal Medicine, University of Health Sciences, Şişli Hamidiye Etfal Health Application and Research Center, 2023

Areas of Interest

  • Obesity and Metabolic Syndrome
  • Diabetes and Insulin Resistance
  • Cholesterol and Lipid Disorders
  • Fatty Liver Disease
  • Thyroid Diseases
  • Bone Metabolism and Vitamin D
  • Hypertension
  • Chronic Fatigue and Unexplained Weakness
  • Iron Deficiency and Anemia
  • Chronic Disease Monitoring
  • Irritable Bowel Syndrome
  • Exercise and Metabolism
  • Geriatric Patient Monitoring
  • Preventive Health and Comprehensive Check-Up in Turkey
  • Internal Medicine Specialist at Liv Hospital Vadistanbul, from November 2025
  • Specialist Doctor at Artvin Ardanuç District State Hospital, 2023–2025
  • Turkish Internal Medicine Specialists Association
  • European Federation of Internal Medicine
  • Association of Internal Medicine Specialists
  • American College of Physicians
  • Publication: When Trimethoprim-Sulfamethoxazole Turns Pernicious: Type 4 Renal Tubular Acidosis in a Diabetic Patient With Sjögren's Syndrome, Cureus, 2025
  • Publication: Frequency of Metabolic Syndrome in Paget's Disease of Bone, Medical Bulletin of Sisli Etfal Hospital, 2022
  • Ongoing Study: Association between Serum 25-Hydroxyvitamin D Levels and Parathyroid Hormone in Adults with Hypovitaminosis D and Preserved Renal Function: A Retrospective Cross-Sectional Study
  • Ongoing Study: Composition of Weight Loss Associated with Incretin-Based Therapy: A Systematic Review and Meta-Analysis of DXA-Measured Lean and Fat Mass in Randomized Controlled Trials
Share :